|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/00 | (2006.01) |
| A61K 31/4745 | (2006.01) | ||
| A61K 31/513 | (2006.01) | ||
| A61K 31/519 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3446706 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18150457.2 |
| Date of filing the European patent application | 2018-01-05 | |
| (97) | Date of publication of the European application | 2019-02-27 |
| (45) | Date of publication and mention of the grant of the patent | 2021-06-02 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 17187682 | 2017-08-24 | EP |
| (72) |
LINDBERG, Per Lennart , SE
SUNDÉN, Gunnel Elisabet , SE
GUSTAVSSON, Bengt , SE
VEDIN, Anders , SE
|
| (73) |
Isofol Medical AB ,
Biotech Center
Arvid Wallgrens Backe 20, 413 46 Göteborg,
SE
|
| (54) | [6R]-MTHF MULTIPLE BOLUS ADMINISTRATION IN 5-FLUOROURACIL BASED CHEMOTHERAPY |
| [6R]-MTHF MULTIPLE BOLUS ADMINISTRATION IN 5-FLUOROURACIL BASED CHEMOTHERAPY |